You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

37 Items

Neoadjuvant or Adjuvant Therapy for Resectable Gastric Cancer

Document Status: Archived
ID: 2-14
Version: 3

Apr 2011

Oral Capecitabine (Xeloda™) in the First-line Treatment of Metastatic Colorectal Cancer

Document Status: Archived
ID: 2-15

Sep 2011

Pemetrexed Monotherapy for the Maintenance Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Non-Squamous Histology

Document Status: Archived
ID: CED 21

Jan 2011

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2010

Document Status: Current
ID: PET 2010-1

Apr 2011

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2010

Document Status: Current
ID: PET 2010-2

Apr 2011

Radionuclide Therapy for Patients with Neuroendocrine Tumors (NETs) in Ontario: Expert Panel Report

Document Status: Current
ID: GL-C50-01

Jan 2011

Recommendations on screening for breast cancer in average-risk women aged 40–74 years

Nov 2011

Single-Agent Interleukin-2 in the Treatment of Metastatic Melanoma

Document Status: Archived
ID: 8-5
Version: 2

Sep 2011

Surgical Management of Early-Stage Invasive Breast Cancer

Document Status: Archived
ID: 1-1
Version: 3

Sep 2011

Surveillance Programs for Early Stage Nonseminomatous Testicular Cancer

Document Status: Archived
ID: 3-5

Nov 2011

Temozolomide for the Treatment of Metastatic Melanoma

Document Status: Archived
ID: 8-4

Sep 2011

Temozolomide Monotherapy for the Treatment of Patients with Glioblastoma that has Relapsed or Progressed Following Prior Therapy

Document Status: Archived
ID: CED 20

Mar 2011